https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/nihr-gosh-brc-spinout-orchard-therapeutics-signs-strategic-agreement-gsk/
NIHR GOSH BRC spinout Orchard Therapeutics signs strategic agreement with GSK
13 Apr 2018, 1:10 p.m.
GSK and Orchard Therapeutics today announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for patients.Orchard Therapeutics is a biotechnology company that develops transformative gene therapies for life threatening rare diseases. Orchard’s founding scientists include NIHR GOSH BRC researchers Professor Bobby Gaspar, Adrian Thrasher and Waseem Qasim. This acquisition strengthens Orchard’s position as a global leader in gene therapy for rare diseases and GSK will continue to invest in the development of its platform capabilities in cell and gene therapies, with a focus on oncology.
This agreement is evidence of GOSH BRC’s continued success in accelerating the delivery of new medicines for patient benefit and is testament to the GOSH BRC’s unique expertise in novel therapies for rare diseases.
Under the agreement, GSK will become an investor in Orchard Therapeutics, receiving a 19.9% equity stake along with a seat on the company’s board. GSK will also receive financial considerations in the form of royalties and commercial milestone payments related to the acquired portfolio. GSK and Orchard will exchange manufacturing, technical and commercial insights and learnings on the development of gene therapy medicines to ensure the success of the assets.
The acquisition of GSK’s programmes complements Orchard’s pipeline of clinical and preclinical gene therapies for primary immune deficiencies and inherited metabolic disorders.
Dr Ian Simcock becomes GOSH’s first Allied Health Professional to receive NIHR postdoctoral fellowship
The five-year fellowship will focus on improving parental choice after pregnancy loss through the development of less-invasive post-mortem investigations.
National conference brings child health research community together
Researchers and clinicians from across the UK gathered at Sheffield City Hall for the inaugural National Paediatric Translational Research Conference
Mum chooses to support research as a legacy for her twins
Understanding how a singular cancer spread between two twins in the womb using genomics - Research from GOSH and the Sanger Institute
Seven years of discovery: seven researchers transforming children's lives at the Zayed Centre for Research
Seven years ago, the Zayed Centre for Research into Rare Disease in Children (ZCR) opened its doors with an ambitious vision at GOSH